From accelerating clinical development to digital health commercial products that differentiate your therapies – digital is playing a pivotal role in biopharma across therapeutic areas.
Each one of these use cases requires a trusted and compliant cloud infrastructure.
Building an in-house digital infrastructure to support your regulated digital health products is a competitive disadvantage for biopharma companies. To drive speed to market and enable your teams to focus on clinical innovation and specific digital health IP that is core to your business, we recommend taking a partner-first approach for your digital health platform.
BrightInsight replaces the need for lengthy and complex ‘build from scratch’ implementations. Instead, we offer a proven platform and configurable applications, built to meet the most stringent global security, privacy, and regulatory requirements.
When building your digital health solutions on the BrightInsight®️ Platform, you are future-proofing compliance while ensuring scalability across geographies.
Our platform reduces the cost of implementation and maintenance, versus a custom solution, and scales across products and global markets.
We accelerate your time to market while lowering costs
A proven platform and team to bring you peace of mind
Top 20 biopharma companies trust BrightInsight to build and launch their commercial regulated digital health products.
“The BrightInsight team proactively identifies and takes transparent action to potential risks. In one instance, BrightInsight implemented a critical operating system patch within 48 hours to mitigate CSL Behring’s risk and eliminate downtime for our patients.”
Brian Johnson, Senior Director, Customer Engagement Management at CSL Behring
We handle global regulatory compliance, so you don’t have to
To be prepared for the future, you need a regulatory strategy for your digital health products now. Most medical Device Data Systems (MDDS) do not offer a sustainable regulatory infrastructure to support digital health solutions as they mature to regulated offerings. BrightInsight is more than just MDDS and supports up to Class III medical devices.
“If you leverage a solution like BrightInsight that meets the most stringent requirements and maintains compliance…you don’t have to worry about your regulated digital solutions in the U.S. versus Europe versus U.K. and so on. You just know they’re compliant.”
Top 10 Pharma Digital Health Executive
Our unwavering commitment to security and privacy minimizes your risk
We provide analytics dashboards to optimize your digital health products
Based in Silicon Valley with teams all over the globe, BrightInsight is backed by leading healthcare and technology VCs. Our leadership team brings over 100 years of combined digital health experience in the biopharma and medtech industries.
Our vision is to transform patient outcomes globally by bringing the power of digital technology to healthcare, and we work every day to achieve this by accelerating regulated digital health innovation for our customers through our scalable medical-grade platform.
We are the launch partner and underlying platform for the world’s leading biopharma companies. Our clients trust BrightInsight to accelerate time to market for their regulated digital health products including apps, algorithms, medical devices, connected combination products, companion diagnostics, and Software as a Medical Device.
"We have found in BrightInsight a partner who shares our commitment to advancing public health with innovative, customer-centric solutions. Our engagement with BrightInsight will enable us to bring our digital health solutions to market faster with the goal of improving patient outcomes."
Brian Armstrong, Senior Vice President, Clinical Operations – North America, bioMérieuxLearn More
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
Brian Johnson, Director, Digital Health, CSL BehringCase Study
"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."
Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo NordiskLearn More